MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-10-2025
Zentalis Pharmaceuticals EV - Enterprise Value 2011-2025 | ZNTL
Annual EV - Enterprise Value Zentalis Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.06 B | 1.06 B | 3.62 B | 1.44 B | -48.2 M | -16.5 M | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 3.62 B | -48.2 M | 1.18 B |
EV - Enterprise Value of other stocks in the Biotechnology industry
| Issuer | EV - Enterprise Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
1.82 B | - | 2.43 % | $ 254 M |  Germany |
 |
Arbutus Biopharma Corporation
ABUS
|
457 M | $ 4.85 | 2.87 % | $ 805 M |  Canada |
 |
Aclaris Therapeutics
ACRS
|
192 M | $ 3.21 | -1.23 % | $ 248 M |  USA |
 |
AlloVir
ALVR
|
-64.1 M | - | 4.14 % | $ 49.1 M | USA |
 |
Aptevo Therapeutics
APVO
|
3.01 M | $ 1.06 | -6.64 % | $ 293 K | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
1.95 B | - | - | $ 40.3 B | USA |
 |
Ascendis Pharma A/S
ASND
|
726 M | $ 215.41 | -2.27 % | $ 5 B |  Danmark |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
3.41 B | - | -1.52 % | $ 24.7 M | USA |
 |
Midatech Pharma plc
MTP
|
4.79 M | - | -18.52 % | $ 27.3 M |  Britain |
 |
Alterity Therapeutics Limited
ATHE
|
-28.9 M | $ 3.15 | -3.85 % | $ 7.58 B |  Australia |
 |
Biophytis SA
BPTS
|
525 M | - | -13.47 % | $ 169 M |  France |
 |
Институт стволовых клеток человека
ISKJ
|
14.1 M | - | - | - |  Russia |
 |
BioVie
BIVI
|
-12.6 M | $ 1.43 | -1.39 % | $ 2.11 M | USA |
 |
ARCA biopharma
ABIO
|
436 M | - | 1052.0 % | $ 415 M | USA |
 |
Acasti Pharma
ACST
|
24 M | - | 4.01 % | $ 150 M | Canada |
 |
Adaptimmune Therapeutics plc
ADAP
|
2.15 B | - | -15.15 % | $ 60.3 M | Britain |
 |
BioNTech SE
BNTX
|
-6.64 B | $ 94.02 | -0.84 % | $ 27.2 B | Germany |
 |
Aeglea BioTherapeutics
AGLE
|
725 M | - | - | $ 1.01 B | USA |
 |
Albireo Pharma
ALBO
|
417 M | - | -0.23 % | $ 916 M | USA |
 |
Alpine Immune Sciences
ALPN
|
363 M | - | - | $ 2.17 B | USA |
 |
Ampio Pharmaceuticals
AMPE
|
-1.05 M | - | -11.43 % | $ 502 K | USA |
 |
Amphastar Pharmaceuticals
AMPH
|
2 B | $ 26.2 | 3.68 % | $ 1.27 B | USA |
 |
Applied Molecular Transport
AMTI
|
7.6 M | - | - | $ 10.1 M | USA |
 |
Anika Therapeutics
ANIK
|
300 M | $ 9.59 | 0.31 % | $ 141 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
647 M | $ 0.27 | -6.08 % | $ 588 M |  Israel |
 |
Arena Pharmaceuticals
ARNA
|
5.65 B | - | -6.81 % | $ 3.04 B | USA |
 |
Athersys
ATHX
|
-37.4 M | - | 3.77 % | $ 22.4 M | USA |
 |
Acer Therapeutics
ACER
|
38.2 M | - | 2.71 % | $ 14 M | USA |
 |
Catalyst Biosciences
CBIO
|
38.1 M | $ 13.48 | -4.36 % | $ 887 M | USA |
 |
Avenue Therapeutics
ATXI
|
-1.23 M | - | -52.27 % | $ 4.45 M | USA |
 |
AVROBIO
AVRO
|
-35.4 M | - | 1083.1 % | $ 745 M | USA |
 |
Axon Enterprise
AXON
|
41.5 B | $ 549.1 | -2.69 % | $ 41.6 B | USA |
 |
Ayala Pharmaceuticals
AYLA
|
5.32 M | - | - | $ 7.46 M | Israel |
 |
Aytu BioScience
AYTU
|
-15.2 M | $ 2.4 | 4.34 % | $ 15.1 M | USA |
 |
AstraZeneca PLC
AZN
|
57.7 B | $ 91.04 | 1.35 % | $ 96.9 B | Britain |
 |
Acorda Therapeutics
ACOR
|
-13.2 M | - | -24.86 % | $ 820 K | USA |
 |
Brickell Biotech
BBI
|
515 K | - | -5.38 % | $ 6.06 M | USA |
 |
Burford Capital Limited
BUR
|
3.22 B | $ 8.87 | -1.55 % | $ 1.45 B | Britain |
 |
BeiGene, Ltd.
BGNE
|
253 B | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
10.2 B | $ 11.23 | -2.69 % | $ 726 M | USA |
 |
Biogen
BIIB
|
28.3 B | $ 174.94 | 0.48 % | $ 25.5 B | USA |
 |
Abeona Therapeutics
ABEO
|
184 M | $ 5.07 | -5.5 % | $ 108 M | USA |
 |
Celldex Therapeutics
CLDX
|
18.3 M | $ 27.11 | -1.47 % | $ 1.75 M | USA |
 |
ADiTx Therapeutics
ADTX
|
23.1 M | $ 1.66 | -25.84 % | $ 21.9 K | USA |
 |
Cellectar Biosciences
CLRB
|
60.8 M | $ 3.36 | -7.32 % | $ 41.1 M | USA |
 |
Bellicum Pharmaceuticals
BLCM
|
-9.74 M | - | -9.72 % | $ 5.89 M | USA |
 |
Berkeley Lights
BLI
|
115 M | - | -7.31 % | $ 87 M | USA |
 |
Advaxis
ADXS
|
-3.02 M | - | -9.65 % | $ 45.9 M | USA |
 |
Завод ДИОД
DIOD
|
3.14 B | - | - | - | Russia |
 |
Фармсинтез
LIFE
|
59.3 B | - | - | - | Russia |